CWBR News and Press, CohBar Inc. From 08/10/21

CohBar (NASDAQ:CWBR): Q2 GAAP EPS of -$0.08 misses by $0.01. Cas and equivalents of $13.8M Shares +14%. Press Release For further details see: CohBar EPS misses by $0.01

MENLO PARK, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today reported its financial results for the second quarter ended June ...

CB4211 was well-tolerated and appeared safe with no serious adverse events Robust reductions in ALT and AST Reduction in glucose and trend towards body weight reduction Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., Aug....

MENLO PARK, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that the company will release its second quarter 2...

MENLO PARK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced an update on the timing for the release of the data for...

Tempest Therapeutics (TPST) +141%.Mer Telemanagement Solutions (MTSL) +56%.Celldex Therapeutics (CLDX) +41% on early-stage data for CDX-0159 in skin condition.SGOCO Group (SGOC) +38%.Antelope Enterprise Holdings (AEHL) +30%.Cemtrex (CETX) +19%.Carver Bancorp (CARV) +15%.Park City Gr...

BSQUARE Corporation (BSQR) +77%.Exela Technologies (XELA) +59% after rollout of its Robotic Process Automation platform.Cerevel Therapeutics Holdings (CERE) +40% after positive results from its early-stage trial of CVL-231.Auddia (AUUD) +37% after launching its flagship app.Ver...

MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced its Chief Executive Officer Dr. Joseph Sarret will pres...

CohBar, Inc. (CWBR) Q1 2021 Earnings Conference Call May 17, 2021 05:00 PM ET Company Participants Jordyn Tarazi - Director of Investor Relations Joe Sarret - Chief Executive Officer Ken Cundy - Chief Scientific Officer Jeff Biunno - Chief Financial Officer Conference Call Participants Kumar ...

CohBar (CWBR): Q1 GAAP EPS of -$0.07 misses by $0.02.CohBar had cash and investments of $17.8 million as of March 31, 2021, compared to $21.0 million as of December 31, 2020. The cash burn for the quarter ended March 31, 2021, was approximately $4.2 million.  Press Release For fur...